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Previous reports have suggested a possible role for vitamin D in the etiology of chronic spontaneous urticaria (CSU); however, little
information is available regarding the role of other micronutrients. We, therefore, analyzed vitamin D, vitamin B12, and ferritin
levels in CSU patients (𝑛 = 282) from a preexisting database at Southampton General Hospital. Data were compared against mean
micronutrient levels of the general population of the UK, obtained from the National Diet and Nutrition Survey. Vitamin D levels
of CSU patients were found to be higher than those of the general UK population (𝑃 = 0.001). B12 levels were lower in patients
with CSU (𝑃 < 0.001) than in the general population. Ferritin levels were found to be lower in male CSU patients than in the
general male population (𝑃 = 0.009). This association between low B12 and iron levels and CSU might indicate a causal link, with
micronutrient replacement as a potential therapeutic option.
1. Introduction
Vitamin D has been suggested to play a role in the aetiology
of chronic spontaneous urticaria (CSU) [1–3]. However, the
roles of other micronutrients in the development of CSU are
unclear. In our clinical immunology practice, we routinely
screen for micronutrient deficiencies in patients referred for
allergy, immunology, and CSU. We observe that some of
our CSU cases exhibit lessening of disease severity upon
supplementing with low levels of vitamin D, vitamin B12,
or iron, but this often happens alongside medical/dietary
interventions that make it difficult to assess the true reason
for symptom improvement. Lower vitamin D levels have
previously been reported in CSU patients by Grzanka et al.
andThorp et al. [1, 2] However, the numbers of CSU patients
enrolled in both of these studies were small (25 and 35, resp.);
therefore, further studies are warranted. Furthermore, Mete
et al. studied 33 patientswithCSUand reported lower vitamin
B12 levels in these patients compared to healthy controls [4].
Recently, Guarneri et al. reported significant improvement
in urticaria after iron supplementation in a subgroup of
CSU patients with iron deficiency and poor response to
antihistamine. A higher prevalence of iron deficiency in CSU
patients compared with healthy individuals was also reported
in this study [5].
2. Materials and Methods
To determine micronutrient levels, vitamin D (25-hydroxyv-
itamin D), vitamin B12, ferritin, mean corpuscular volume
(MCV), and mean corpuscular haemoglobin concentration
(MCHC) levels of 1616 patients with CSU and other common
presentations seen in the allergy clinic were extracted from a
database at Southampton General Hospital (SGH). Patients
between the ages of 19 and 64 years were included (mean
age [years] ± SD, vitamin D: 41.2 ± 12.41 years; vitamin
B12: 41.9 ± 12.40 years; ferritin: 41.0 ± 11.72 years). This
was compared with the National Diet and Nutrition Survey
(NDNS) conducted between 2008 and 2012 [6]. We also
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Table 1: Differences in micronutrient levels between SGH patients and the general UK population, aged 19 to 64 years.
CSU patients in SGH
(mean ± SD)
Normal population in NDNS
(mean ± SD) P value
Vitamin D levels (nmol/L) 51.4 ± 27.03(𝑛 = 225)
45.4 ± 24.84
(𝑛 = 1321) 0.001
Vitamin D levels (nmol/L), females 53.1 ± 27.51(𝑛 = 163)
47.3 ± 25.61
(𝑛 = 770) 0.010
Vitamin D levels (nmol/L), males 46.8 ± 25.38(𝑛 = 62)
43.5 ± 23.87
(𝑛 = 551) 0.306
Vitamin B12 levels (ng/L) 284 ± 108.4(𝑛 = 176)
359 ± 131.2
(𝑛 = 1320) <0.001
Vitamin B12 levels (ng/L), females 281 ± 113.8(𝑛 = 133)
359 ± 132.2
(𝑛 = 768) <0.001
Vitamin B12 levels (ng/L), males 295 ± 89.7(𝑛 = 43)
359 ± 130.2
(𝑛 = 552) 0.002
Ferritin levels (ug/L) 61 ± 57.0(𝑛 = 188)
97 ± 90.2
(𝑛 = 1329) <0.001
Ferritin levels (ug/L), females 48 ± 44.4(𝑛 = 140)
56 ± 53.6
(𝑛 = 775) 0.096
Ferritin levels (ug/L), males 101 ± 70.3(𝑛 = 48)
140 ± 100.6
(𝑛 = 554) 0.009
Definition of micronutrient deficiency: vitamin D < 50 nmol/L; vitamin B12 < 130 ng/L; ferritin < 11 ug/L for females; ferritin < 24 ug/L for males. NDNS: the
National Diet and Nutrition Survey; SGH: Southampton General Hospital.
collected data on sex, date of birth, date of blood test, and the
clinical descriptions provided when testing was requested.
For vitamin D analysis, we investigated a number of samples
collected during different months to determine the potential
influence of seasonal variation.
According to the clinical descriptions, only nutrient
investigations requested for CSU were included. Patients
known to have received nutrient replacement were excluded.
To minimize bias resulting from supplementation of nutri-
ents, we excluded data from repetitive tests, unless the
nutrient levels remained low or the first result was so
high that further supplementation was very unlikely. Testing
requested for hereditary angioedema, angioedema related to
angiotensin-converting enzyme inhibitors, physical urticaria,
acute urticaria/angioedema, urticarial vasculitis, or autoin-
flammatory syndrome was excluded. Also patients with
diagnoses of celiac disease or upper gastrointestinal tract
surgery were excluded.
We analysed mean nutrient levels and the proportion of
CSU patients with a nutrient deficiency. Data from NDNS
were age-matched to our cohort to establish normal pop-
ulation micronutrient levels [6]. Differences between our
data and mean nutrient concentrations in the NDNS sample
were analysed by using 𝑡-tests. All statistical analyses were
performed using GraphPad Prism software, version 6 (La
Jolla, CA, USA). Statistical significance was defined at 𝑃
values of 0.05 or less.
3. Results and Discussion
Of the 1616 patients extracted from the SGH database, 282
patients were identified as having CSU. Most of the CSU
patients were female. Vitamin D levels were higher in the
CSU patients than in the general UK population (mean
vitamin D ± SD, 51.4 ± 27.03 versus 45.4 ± 24.84 nmol/L;
𝑃 = 0.001; Table 1). However, the majority of people with
urticaria (54.6%) had vitamin D levels below 50 nmol/L.
The proportion of samples collected in summer and autumn
(between June and November) was 54.1%.
Compared with the general UK population, CSU patients
had significantly lower levels of vitamin B12 but were still
within the normal range (mean vitamin B12 ± SD, 284±108.4
versus 359 ± 131.2 ng/L; 𝑃 < 0.001). In addition, lower
ferritin levels were observed in CSU patients of both sexes
(mean ferritin ± SD, female: 48 ± 44.4 versus 56 ± 53.6 ug/L;
male: 101 ± 70.3 versus 140 ± 100.6 ug/L), but the difference
was not significantly lower in female CSU patients (female:
𝑃 = 0.096, versus male: 𝑃 = 0.009) compared to the
general female population. The proportions of patients with
low B12 (below 130 ng/L) and low ferritin (below 11 ug/L for
females and below 24 ug/L for males) levels were 4.5% and
8.5%, respectively. Because full blood count (FBC) testing is
recommended by most mainstream urticaria guidelines, we
investigated the usefulness of MCV in screening for B12 or
iron deficiencies. Out Of 16 patients with low ferritin, only six
had MCV values below 80 fL and none had low MCHC. On
the other hand, none of the eight patients with low vitamin
B12 levels exhibited MCV values above 100 fL.
Therefore, in contrast with the results of previous studies
[1, 2], we observed higher vitamin D levels in our CSU
population in comparison with the UK general population.
One possible explanation might be the reported effect of
latitude in the wide variation of vitamin D levels in the UK
population and the southern location of our catchment area
[7]. However, we cannot prove it due to the lack of data on
vitamin D levels of the general population in Southampton.
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Although the previous cohort reported byMete et al. (𝑛 =
33) [4] was much smaller than that in our current study, both
studies suggest that lower B12 levels are associated with CSU.
We also observed an association between iron and CSU, in
agreement with a previous study [5]. However, the prevalence
of iron deficiency in CSU patients was much lower in our
study (16/188 versus 81/122). Even though the low sensitivity
of erythropoietin parameters in the diagnosis of B12 or iron
deficiency has been previously reported [8, 9], it is worth
noting that FBC alone is not helpful in excluding B12 or iron
deficiencies.
We acknowledge the limitations of this study, including
the fact that we did not record dietary or medication history
for our cohort; it is possible that variances in diet account
for micronutrient differences. For example, an increasing
number of patients are taking vitamin D supplements due
to increased public awareness. Nevertheless, we suggest that
the lower vitamin B12 and iron levels in CSU patients
in our study may indicate that these micronutrients are
interesting possible candidates for a role in the initiation or
possibly maintenance of CSU. Although the mechanism is
still unknown, it could be hypothesized that micronutrients
regulate cytokine release following mast cell degranulation
by their immunomodulatory properties. Wheatley reported
an inverse relationship between vitamin B12 and tumour
necrosis factor alpha [10], which is upregulated in CSU
patients [11]. Iron-induced decreases in the number of mast
cell granules and percentage of mast cell degranulation have
also been observed in vitro [12].
4. Conclusions
Whether the “low-normal” B12 and ferritin levels seen in
most of our CSU cohort reflect either inadequate diets or an
etiological role is unclear; however the effect of more general
supplementation remains to be established, and a dietary
intervention study would be an exciting prospect in this
disease area. Further information regarding dietary intake
and food avoidance habits of patients with CSU will serve to
build on our observations.
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